Kayne Anderson Rudnick Investment Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $43.7 Billion
- Q3 2024
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 5,746 shares of REGN stock, worth $3.87 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,746
Previous 5,657
1.57%
Holding current value
$3.87 Million
Previous $5.95 Million
1.6%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
83MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.27 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.04 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.3 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.89 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...